F
Félix Gutiérrez
Researcher at Universidad Miguel Hernández de Elche
Publications - 321
Citations - 10243
Félix Gutiérrez is an academic researcher from Universidad Miguel Hernández de Elche. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 48, co-authored 302 publications receiving 8638 citations. Previous affiliations of Félix Gutiérrez include Hospital General Universitario Gregorio Marañón & Carlos III Health Institute.
Papers
More filters
Journal ArticleDOI
Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study.
Esteban Martínez,Maria Larrousse,Josep M. Llibre,Félix Gutiérrez,Maria Saumoy,Antonio Antela,Hernando Knobel,Javier Murillas,Juan Berenguer,Judit Pich,Ignacio Pérez,José M. Gatell +11 more
TL;DR: In patients with sustained virological suppression on ritonavir-boosted protease inhibitor-based therapy, switching to raltegravir demonstrated noninferior efficacy and resulted in a better lipid profile at 48 weeks than continuing riton Cavir- boosted protease inhibitors.
Journal ArticleDOI
The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens.
Félix Gutiérrez,Mar Masiá,Carlos Mirete,Bernardo Soldán,Juan Carlos Rodríguez,Sergio Padilla,Ildefonso Hernández,Gloria Royo,Alberto Martin-Hidalgo +8 more
TL;DR: Age and gender have a strong influence on the overall incidence of CAP and on the incidence of pneumonia caused by the main microbial pathogens, including not only Streptococcus pneumoniae, but also influenza virus, Chlamydophila spp.
Journal ArticleDOI
Usefulness of Procalcitonin Levels in Community-Acquired Pneumonia According to the Patients Outcome Research Team Pneumonia Severity Index
Mar Masiá,Félix Gutiérrez,Conrado Shum,Sergio Padilla,Juan Carlos Navarro,Emilio Flores,Ildefonso Hernández +6 more
TL;DR: While procalcitonin may have a role to predict the microbial etiology in patients with a low PSI score, in patients classified within high PSI risk classes, it is a prognostic marker rather than a predictor of etiology.
Journal ArticleDOI
CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE
James B. Young,Mina Psichogiou,Laurence Meyer,Sylvie Ayayi,Sophie Grabar,François Raffi,Peter Reiss,Brian Gazzard,Mike Sharland,Félix Gutiérrez,Niels Obel,Ole Kirk,José M. Miró,Hansjakob Furrer,Antonella Castagna,Stéphane De Wit,Josefa Muñoz,Jesper Kjaer,Jesper Grarup,Geneviève Chêne,Heiner C. Bucher +20 more
TL;DR: Using data from the Collaboration of Observational HIV Epidemiological Research Europe, Jim Young and colleagues show that in successfully treated patients the risk of a new AIDS event or death follows a CD4 cell count gradient in patients with viral suppression.
Journal ArticleDOI
Microbiology and outcome of iliopsoas abscess in 124 patients.
Vicente Navarro López,José Ramos,Victoria Meseguer,José Luis Pérez Arellano,Regino Serrano,Miguel Angel García Ordóñez,Galo Peralta,Vicente Boix,Javier Rosales Pardo,Alicia Conde,Fernando Salgado,Félix Gutiérrez +11 more
TL;DR: Primary IPA is more prevalent than primary IPA among those with secondary IPA, and most abscesses are secondary to a skeletal source; the overall prognosis of patients with this condition is good.